TbpB-based oral mucosal vaccine provides heterologous protection against Glasser disease caused by different serovars of Spanish field isolates of Glaesserella parasuis
Alba González-Fernández, Óscar Mencía‐Ares, María José García Iglesias, Máximo Petrocchi-Rilo, Rubén Miguélez-Pérez, Alberto Perelló, Elena Herencia-Lagunar, Vanessa Acebes-Fernández, César Bernardo Gutiérrez-Martín, Sonia Martínez-Martínez
This study shows an oral mucosal TbpB-based vaccine protects piglets against multiple G. parasuis serovars by reducing bacterial colonization and improving survival.
Porcine Health Management · Nov 28, 2024Peer-reviewedImmunology